People

Chuck Cleland
Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
Education
PhD, Psychology, New School for Social Research
MA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College

Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis
BIO
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta­-analysis, respondent­ driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.
Publications

Recent

Strayhorn JC, Cleland CM, Vanness DJ, Wilton L, Gwadz M, Collins LM (2024).
Using decision analysis for intervention value efficiency to select optimized interventions in the multiphase optimization strategy
Health Psychology, 43 (2), 89-100. doi: 10.1037/hea0001318. PMCID: PMC10837328.

Scanlon F, Remch M, Scheidell JD, Brewer R, Dyer TV, Albis-Burdige B, Irvine N, Turpin R, Parker S, Cleland CM, Hucks-Ortiz C, Gaydos CA, Mayer KH, Khan MR (2024).
Posttraumatic stress disorder symptoms and incarceration: The impact on sexual risk-taking, sexually transmitted infections, and depression among Black sexual minority men in HIV Prevention Trials Network (HPTN) 061
Psychology of Men and Masculinities, 25 (1), 44-56. doi: 10.1037/men0000458.

Palamar JJ, Salomone A, Massano M, Cleland CM (2023).
Trends in reported and biologically confirmed drug use among people who use ecstasy in the nightclub/festival-attending population, 2016–2022
Drug and Alcohol Dependence Reports, 9, 100198. doi: 10.1016/j.dadr.2023.100198. PMCID: PMC10665664.

Feelemyer J, Bershteyn A, Scheidell JD, Brewer R, Dyer TV, Cleland CM, Hucks-Ortiz C, Justice A, Mayer K, Grawert A, Kaufman JS, Braithwaite S, Khan MR (2023).
Impact of decarceration plus alcohol, substance use, and mental health screening on life expectancies of Black sexual minority men and Black transgender women (BSMM/BTW) living with HIV in the United States: A simulation study based on HPTN 061
Journal of Acquired Immune Deficiency Syndromes [Epub 2023 Nov 28]. doi: 10.1097/QAI.0000000000003354.

Palamar JJ, Cleland CM, Vincenti M, Salomone A (2023).
A multivariable analysis delineating hair color, hair dyeing, and hat wearing as predictors of level of cocaine and MDMA detection in human hair samples
Drug Testing and Analysis [Epub 2023 Nov 20]. doi: 10.1002/dta.3607.


Notable

Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK (2014).
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.

Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .

Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.

Dr. Cleland's Research Gate Profile
Selected Press